Tags

Type your tag names separated by a space and hit enter

Astigmatism management in cataract surgery with the AcrySof toric intraocular lens.
J Cataract Refract Surg. 2008 Sep; 34(9):1483-8.JC

Abstract

PURPOSE

To present clinical data from a single-center prospective clinical trial of the AcrySof toric intraocular lens (IOL).

SETTING

Academic Hospital Maastricht, Maastricht, The Netherlands.

METHODS

Fifty-three eyes (43 patients) had implantation of an AcrySof toric IOL. Three toric models were evaluated in cylinder powers of 1.50 diopters (D) (SN60T3; T3 group, n = 16), 2.25 D (SN60T4; T4 group, n = 14), and 3.00 D (SN60T5; T5 group, n = 23) at the IOL plane. The T5 group was subdivided into eyes that could be fully corrected (T5a, n = 13) and eyes that could be partially corrected (T5b, n = 10).

RESULTS

Four months postoperatively, the mean uncorrected visual acuity (UCVA) was 0.77 +/- 0.23 in the T3 group, 0.93 +/- 0.23 in the T4 group, 0.82 +/- 0.15 in the T5a group, and 0.47 +/- 0.13 in the T5b group. More than 90% of the combined eyes in the T3, T4, and T5a groups achieved a UCVA of 20/40 or better, and almost 80% achieved a UCVA of 20/25 or better. Residual refractive astigmatism of less than 0.75 D was achieved in 74% of eyes and of less than 1.00 D in 91%. The mean IOL misalignment was 2.5 +/- 2.1 degrees in the T3 group, 3.5 +/- 2.3 degrees in the T4 group, and 4.1 +/- 3.5 degrees in the T5 group.

CONCLUSION

Implantation of the AcrySof toric IOL proved to be an effective, safe, and predictable method of managing corneal astigmatism in cataract patients.

Authors+Show Affiliations

Department of Ophthalmology, Academic Hospital Maastricht, Debyelaan 25, Maastricht, The Netherlands. noelbauer@gmail.comNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Comparative Study
Journal Article

Language

eng

PubMed ID

18721707

Citation

Bauer, Noël J C., et al. "Astigmatism Management in Cataract Surgery With the AcrySof Toric Intraocular Lens." Journal of Cataract and Refractive Surgery, vol. 34, no. 9, 2008, pp. 1483-8.
Bauer NJ, de Vries NE, Webers CA, et al. Astigmatism management in cataract surgery with the AcrySof toric intraocular lens. J Cataract Refract Surg. 2008;34(9):1483-8.
Bauer, N. J., de Vries, N. E., Webers, C. A., Hendrikse, F., & Nuijts, R. M. (2008). Astigmatism management in cataract surgery with the AcrySof toric intraocular lens. Journal of Cataract and Refractive Surgery, 34(9), 1483-8. https://doi.org/10.1016/j.jcrs.2008.05.031
Bauer NJ, et al. Astigmatism Management in Cataract Surgery With the AcrySof Toric Intraocular Lens. J Cataract Refract Surg. 2008;34(9):1483-8. PubMed PMID: 18721707.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Astigmatism management in cataract surgery with the AcrySof toric intraocular lens. AU - Bauer,Noël J C, AU - de Vries,Niels E, AU - Webers,Carroll A B, AU - Hendrikse,Fred, AU - Nuijts,Rudy M M A, PY - 2008/03/05/received PY - 2008/05/20/accepted PY - 2008/8/30/pubmed PY - 2008/10/4/medline PY - 2008/8/30/entrez SP - 1483 EP - 8 JF - Journal of cataract and refractive surgery JO - J Cataract Refract Surg VL - 34 IS - 9 N2 - PURPOSE: To present clinical data from a single-center prospective clinical trial of the AcrySof toric intraocular lens (IOL). SETTING: Academic Hospital Maastricht, Maastricht, The Netherlands. METHODS: Fifty-three eyes (43 patients) had implantation of an AcrySof toric IOL. Three toric models were evaluated in cylinder powers of 1.50 diopters (D) (SN60T3; T3 group, n = 16), 2.25 D (SN60T4; T4 group, n = 14), and 3.00 D (SN60T5; T5 group, n = 23) at the IOL plane. The T5 group was subdivided into eyes that could be fully corrected (T5a, n = 13) and eyes that could be partially corrected (T5b, n = 10). RESULTS: Four months postoperatively, the mean uncorrected visual acuity (UCVA) was 0.77 +/- 0.23 in the T3 group, 0.93 +/- 0.23 in the T4 group, 0.82 +/- 0.15 in the T5a group, and 0.47 +/- 0.13 in the T5b group. More than 90% of the combined eyes in the T3, T4, and T5a groups achieved a UCVA of 20/40 or better, and almost 80% achieved a UCVA of 20/25 or better. Residual refractive astigmatism of less than 0.75 D was achieved in 74% of eyes and of less than 1.00 D in 91%. The mean IOL misalignment was 2.5 +/- 2.1 degrees in the T3 group, 3.5 +/- 2.3 degrees in the T4 group, and 4.1 +/- 3.5 degrees in the T5 group. CONCLUSION: Implantation of the AcrySof toric IOL proved to be an effective, safe, and predictable method of managing corneal astigmatism in cataract patients. SN - 0886-3350 UR - https://www.unboundmedicine.com/medline/citation/18721707/Astigmatism_management_in_cataract_surgery_with_the_AcrySof_toric_intraocular_lens_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0886-3350(08)00621-4 DB - PRIME DP - Unbound Medicine ER -